Videos

Conference Coverage

Addition of Ovarian Function Suppression to Antihormonal Therapy Demonstrates Promise in HR-Positive, HER2-Positive Early Breast Cancer

10/31/2024

Sung Gwe Ahn, MD, PhD, discusses exploratory analysis results from the HERA trial which demonstrated that the addition of ovarian function suppression to antihormonal therapy shows promise in patients with HR-positive, HER2-positive early...

Sung Gwe Ahn, MD, PhD, discusses...

10/31/2024

Oncology

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Conference Coverage

Assessing HER2-Low/-Ultralow Status Could Change Treatment Landscape for Patients With HR-Positive Metastatic Breast Cancer

10/29/2024

Giuseppe Viale, MD, discusses results from a comparison study which demonstrated that reassessing local and central immunostaining results can identify more patients with HER2-low or HER2-ultralow expression eligible for trastuzumab...

Giuseppe Viale, MD, discusses...

10/29/2024

Oncology

Conference Coverage

Exploring the Current Treatment Landscape for Patients With Extramedullary MM

10/29/2024

At the 2024 Lymphoma, Leukemia & Myeloma Congress, Saad Usmani, MD, discusses optimal strategies and the current treatment landscape for patients with extramedullary multiple myeloma.

At the 2024 Lymphoma, Leukemia &...

10/29/2024

Lymphoma, Leukemia & Myeloma Network

In today’s world, fear and confusion around fentanyl are prevalent, especially among those of us in emergency care.

Videos

Pediatric Video Tutorial: Facts vs. Fallacies of Medical Fentanyl

10/29/2024

In today’s world, fear and confusion around fentanyl are prevalent, especially among those of us in emergency care.

In today’s world, fear and...

10/29/2024

EMSWorld

Conference Coverage

Novel Advancements in Marginal Zone Lymphoma Research

10/29/2024

At the 2024 Lymphoma, Leukemia & Myeloma Congress, Peter Martin, MD, discusses recent data and updates in marginal zone lymphoma research.

At the 2024 Lymphoma, Leukemia &...

10/29/2024

Lymphoma, Leukemia & Myeloma Network

Conference Coverage

Evan Dellon, MD, on Guidelines for EoE

10/28/2024

Dr Dellon, from the University of North Carolina, reviews a recent update to guidelines for eosinophilic esophagitis.

Dr Dellon, from the University...

10/28/2024

Gastroenterology

Videos

Best Management of a Patient With BRAF-Altered Recurrent or Refractory Pediatric Low-Grade Glioma

10/28/2024

Matthew Cascio, MD, discusses the course of treatment he would take for a patient with BRAF V600E-mutated pediatric ganglioglioma.

Matthew Cascio, MD, discusses...

10/28/2024

Oncology

Conference Coverage

Miguel Regueiro, MD, on the Safety of JAK Inhibitors in IBD

10/28/2024

Dr Regueiro reports from the ACG Scientific Meeting that a study of Janus kinase (JAK) inhibitors for treatment of ulcerative colitis and Crohn's disease provided reassurance of the safety of these small molecules.

Dr Regueiro reports from the ACG...

10/28/2024

Advances in Inflammatory Bowel Disease Network

Conference Coverage

Identifying Unmet Clinical Needs in Treating Patients With Extramedullary MM

10/28/2024

At the 2024 Lymphoma, Leukemia & Myeloma Congress, Mark Bustoros, MD, shares expert insight into the unmet clinical needs in targeting and treating patients with extramedullary multiple myeloma, an aggressive subtype of myeloma.

At the 2024 Lymphoma, Leukemia &...

10/28/2024

Lymphoma, Leukemia & Myeloma Network